Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 228617

Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.


Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report. // Book of Abstracts, The 12th International Prostate Cancer Update / David E Crawford (ur.).
Denver, Co, USA: ICPME, 2002. str. 363-363 (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 228617 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.

Autori
Tarle, Marko ; Kraljić, Ivo ; Kovačić, Ksenija

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Book of Abstracts, The 12th International Prostate Cancer Update / David E Crawford - Denver, Co, USA : ICPME, 2002, 363-363

Skup
The 12th International Prostate Cancer Update

Mjesto i datum
Keystone, Co, USA, 6-10.02.2002

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
prostate cancer; Stage D3; chemotherapy; advantage phase II over phase I protocol; improvement in bone lesions

Sažetak
In a case of Stage D3 prosatte cancer we have shown the superiority of phase II protocol over phase I with a substantail improvement in PSA and PAP level and even more in none metastases.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0134003

Ustanove:
KBC "Sestre Milosrdnice"


Citiraj ovu publikaciju:

Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija
Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report. // Book of Abstracts, The 12th International Prostate Cancer Update / David E Crawford (ur.).
Denver, Co, USA: ICPME, 2002. str. 363-363 (predavanje, međunarodna recenzija, sažetak, znanstveni)
Tarle, M., Kraljić, I. & Kovačić, K. (2002) Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.. U: David E Crawford (ur.)Book of Abstracts, The 12th International Prostate Cancer Update.
@article{article, author = {Tarle, Marko and Kralji\'{c}, Ivo and Kova\v{c}i\'{c}, Ksenija}, year = {2002}, pages = {363-363}, keywords = {prostate cancer, Stage D3, chemotherapy, advantage phase II over phase I protocol, improvement in bone lesions}, title = {Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.}, keyword = {prostate cancer, Stage D3, chemotherapy, advantage phase II over phase I protocol, improvement in bone lesions}, publisher = {ICPME}, publisherplace = {Keystone, Co, USA} }
@article{article, author = {Tarle, Marko and Kralji\'{c}, Ivo and Kova\v{c}i\'{c}, Ksenija}, year = {2002}, pages = {363-363}, keywords = {prostate cancer, Stage D3, chemotherapy, advantage phase II over phase I protocol, improvement in bone lesions}, title = {Phase I and Phase II Docetaxel-Estramustine therapy in Stage D3 prostate cancer patients, A case report.}, keyword = {prostate cancer, Stage D3, chemotherapy, advantage phase II over phase I protocol, improvement in bone lesions}, publisher = {ICPME}, publisherplace = {Keystone, Co, USA} }




Contrast
Increase Font
Decrease Font
Dyslexic Font